The Traderszone Network

Published in TZ Latest News 4 November, 2015 by The TZ Newswire Staff

ABLYNX’S PARTNER BOEHRINGER INGELHEIM PRESENTED POSITIVE IN VIVO PROOF-OF-MECHANISM DATA WITH BI-SPECIFIC NANOBODY AT EURO GLOBAL SUMMIT ON CANCER THERAPY